Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
(1H-azol-1-ylmethyl)substituted quinoline derivatives, compositions containing the same, and methods of treating mammals suffering from disorders which are characterized by an increased proliferation and/or abnormal differentiation of epithelial tissues.
patent: 4410539 (1983-10-01), Cross et al.
patent: 4792561 (1988-12-01), Walker et al.
patent: 4859684 (1989-08-01), Raeymaekers et al.
Freyne Eddy J. E.
Raeymaekers Alfons H. M.
Sanz Gerard C.
Venet Marc G.
Ivy C. Warren
Janssen Pharmaceutica N.V.
Metz Charles J.
(1H-azol-1-ylmethyl)substituted quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with (1H-azol-1-ylmethyl)substituted quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1H-azol-1-ylmethyl)substituted quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1706606